AstraZeneca (AZN) News Today $66.29 +1.42 (+2.19%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$66.63 +0.34 (+0.51%) As of 04/11/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Act Two Investors LLC Lowers Holdings in AstraZeneca PLC (NASDAQ:AZN)Act Two Investors LLC reduced its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 58.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,396 shares of the company's stock afterApril 13 at 8:10 AM | marketbeat.comZacks Research Decreases Earnings Estimates for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Analysts at Zacks Research decreased their Q1 2026 earnings estimates for shares of AstraZeneca in a research note issued on Wednesday, April 9th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $1.15 per shareApril 13 at 8:02 AM | marketbeat.comDymon Asia Capital Singapore PTE. LTD. Invests $1.05 Million in AstraZeneca PLC (NASDAQ:AZN)Dymon Asia Capital Singapore PTE. LTD. purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 16,000 shares of the company's stock, valued at approximately $1,048,00April 13 at 7:27 AM | marketbeat.comTexas Capital Bancshares Inc TX Takes Position in AstraZeneca PLC (NASDAQ:AZN)Texas Capital Bancshares Inc TX acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,170 shares of the company'sApril 13 at 7:26 AM | marketbeat.comScotia Capital Inc. Sells 181,745 Shares of AstraZeneca PLC (NASDAQ:AZN)Scotia Capital Inc. lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 43.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 231,797 shares of the company's stock after selling 181,745 shares during the quarter. ScoApril 13 at 6:27 AM | marketbeat.comDRW Securities LLC Lowers Stake in AstraZeneca PLC (NASDAQ:AZN)DRW Securities LLC lowered its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 86.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,214 shares of the company's stock after selling 32,254 sApril 13 at 6:09 AM | marketbeat.comZacks Research Has Weak Outlook for AstraZeneca Q1 EarningsApril 13 at 2:01 AM | americanbankingnews.comFirst Foundation Advisors Trims Position in AstraZeneca PLC (NASDAQ:AZN)First Foundation Advisors cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 190,171 shares of the company's stock after selling 14,241 shares during the period. First FouApril 12 at 9:53 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Phoenix Financial Ltd.Phoenix Financial Ltd. grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1,624.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,234,220 shares of the company's stock after purchaApril 12 at 7:25 AM | marketbeat.comBank of Montreal Can Sells 2,045,041 Shares of AstraZeneca PLC (NASDAQ:AZN)Bank of Montreal Can cut its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 66.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,026,292 shares of the company's stock after selling 2,045,041 shares during theApril 12 at 5:49 AM | marketbeat.comCerity Partners LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)Cerity Partners LLC grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 207,860 shares of the company's stock after buying an additional 8April 12 at 5:45 AM | marketbeat.comFederated Hermes Inc. Decreases Holdings in AstraZeneca PLC (NASDAQ:AZN)Federated Hermes Inc. decreased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,595 shares of the company's stock afterApril 12 at 5:39 AM | marketbeat.comAstraZeneca’s AGM Approves All Resolutions, Marks Board ChangesApril 11 at 1:13 PM | tipranks.comAstraZeneca (NASDAQ:AZN) Shares Gap Down - Here's WhyAstraZeneca (NASDAQ:AZN) Shares Gap Down - Should You Sell?April 11 at 12:12 PM | marketbeat.comThis Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.April 11 at 8:28 AM | barrons.comAzimuth Capital Investment Management LLC Buys 69,005 Shares of AstraZeneca PLC (NASDAQ:AZN)Azimuth Capital Investment Management LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 136.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 119,575 shares of the companyApril 11 at 6:54 AM | marketbeat.comAutos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackApril 10 at 4:45 AM | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comPharma Stocks Slide Further After Trump Reiterates Tariff Threats on DrugsApril 9, 2025 | wsj.comPharmaceutical stocks fall as Trump doubles down on tariffs threatApril 9, 2025 | cnbc.comWhy Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped TodayApril 9, 2025 | fool.comWhy Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped TodayApril 9, 2025 | fool.comFmr LLC Sells 805,930 Shares of AstraZeneca PLC (NASDAQ:AZN)Fmr LLC lessened its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 22,311,517 shares of the company's stock after selling 805,930 shares during the quarter. Fmr LLC owned aApril 9, 2025 | marketbeat.comPolymer Capital Management HK LTD Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Polymer Capital Management HK LTD bought a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,350 shares of the company's stockApril 9, 2025 | marketbeat.comPeapack Gladstone Financial Corp Sells 47,590 Shares of AstraZeneca PLC (NASDAQ:AZN)Peapack Gladstone Financial Corp reduced its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 31.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 102,015 shares of the company's stock after selling 47,590 shApril 9, 2025 | marketbeat.comRussell Investments Group Ltd. Raises Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Russell Investments Group Ltd. boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 891,858 shares of the company's stock afterApril 9, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $232.44 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)Envestnet Asset Management Inc. lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,547,564 shares of the company's stock afApril 9, 2025 | marketbeat.com3 No-Brainer Growth Stocks to Buy for Less Than $100April 9, 2025 | fool.com3 No-Brainer Growth Stocks to Buy for Less Than $100April 9, 2025 | fool.comOLD Mission Capital LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)OLD Mission Capital LLC cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 99.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,943 shares of the company's stock after selling 451,759 shares during the period. OLD MissionApril 9, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives $89.75 Consensus Target Price from AnalystsApril 9, 2025 | americanbankingnews.comSpringhill Fund Asset Management HK Co Ltd Takes Position in AstraZeneca PLC (NASDAQ:AZN)Springhill Fund Asset Management HK Co Ltd bought a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 76,500 shares of the company's stock, valued at approximApril 8, 2025 | marketbeat.comTeva, Samsung Bioepis launch biosimilar against AstraZeneca’s SolirisApril 7, 2025 | msn.comSit Investment Associates Inc. Reduces Position in AstraZeneca PLC (NASDAQ:AZN)Sit Investment Associates Inc. decreased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 30.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 166,850 shares of the company's stock after selling 73,050 shares during the quarteApril 7, 2025 | marketbeat.comArete Wealth Advisors LLC Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)Arete Wealth Advisors LLC increased its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 98.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,474 shares of the company's stock after buying an additionApril 7, 2025 | marketbeat.comNational Bank of Canada FI Has $11.65 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)National Bank of Canada FI raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 177,813 shares of the company's stock after acquiring an additional 19,484 shares during the perioApril 7, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Buy" from BrokeragesShares of AstraZeneca PLC (NASDAQ:AZN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the ten ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and twoApril 7, 2025 | marketbeat.comPitcairn Co. Cuts Stake in AstraZeneca PLC (NASDAQ:AZN)Pitcairn Co. lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,296 shares of the company's stock after selling 3,479 sharesApril 6, 2025 | marketbeat.comAstraZeneca (NASDAQ:AZN) Shares Gap Up - What's Next?AstraZeneca (NASDAQ:AZN) Shares Gap Up - Time to Buy?April 5, 2025 | marketbeat.comCinctive Capital Management LP Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)Cinctive Capital Management LP grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 88.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,653 shares of the company's stock after buying an addApril 5, 2025 | marketbeat.comAstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi SankyoApril 5, 2025 | finance.yahoo.comAstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of TherapyApril 5, 2025 | seekingalpha.comAstraZeneca's metastatic breast cancer treatment gets EU nodApril 4, 2025 | msn.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Martin Investment Management LLCMartin Investment Management LLC grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 308,489 shares of the company'April 4, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Nomura Asset Management Co. Ltd.Nomura Asset Management Co. Ltd. reduced its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 76.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,180 shares of the company's stock after selling 66,990 shares durinApril 4, 2025 | marketbeat.comWhy a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on ThursdayApril 3, 2025 | fool.comPotomac Fund Management Inc. ADV Takes $1.10 Million Position in AstraZeneca PLC (NASDAQ:AZN)Potomac Fund Management Inc. ADV purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 16,763 shares of the company's stock, valued atApril 3, 2025 | marketbeat.comMay Hill Capital LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)May Hill Capital LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 4,525 shares of the company's stock, valued at approximately $296,000. A numberApril 3, 2025 | marketbeat.comMosaic Financial Group LLC Makes New $369,000 Investment in AstraZeneca PLC (NASDAQ:AZN)Mosaic Financial Group LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,638 shares of the company's stock, valued at approximately $369,000. Several other hedge fundsApril 2, 2025 | marketbeat.com Remove Ads Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.820.99▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼4225▲AZN Articles Average Week Remove Ads Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Intra-Cellular Therapies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
